The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

( NewsNation) — Novo Nordisk has ended a partnership with U.S. telehealth company Hims & Hers, citing deceptive marketing and ...

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Key Takeaways Hims & Hers shares plunged 30% in intraday trading Monday after Novo Nordisk said it is pulling Wegovy from the ...